PMC6317834_01
The alpha-fetoprotein level was notably elevated in the absence of hepatocellular carcinoma at 9 months post-liver transplant, and the level normalized after interferon therapy. PSL, methylprednisolone/prednisolone; MMF, mycophenolate mofetil; TAC, tacrolimus; SNMC, stronger neo-minophagen C; EVR, everolimus; LT, liver transplantation; SOF, sofosbuvir; RBV, ribavirin; PET, positron emission tomography; CT, computed tomography; PEG-IFN, pegylated-interferon; AST, aspartate aminotransferase; T-BIL, total bilirubin; HCV, hepatitis C virus; AFP, alpha-fetoprotein; DCP, des-gamma-carboxy prothrombin; HCC, hepatocellular carcinoma.
CG-CGCR180091F001.jpg
PMC6317834_01_CG-CGCR180091F001.jpg
F1
We started the patient on an immunosuppressant cocktail of tacrolimus, mycophenolate mofetil, and a steroid (methylprednisolone/prednisolone) (Figure 1).
Post-liver transplant images: (A) Abdominal computed tomography. (B) Fluorodeoxyglucose-PET (FDG-PET) and CT scans of the liver. (C) FDG-PET and CT scan of the whole body 8 months after transplant. No malignancy was apparent.
CG-CGCR180091F002.jpg
PMC6317834_01_CG-CGCR180091F002.jpg
F2
Fluorodeoxyglucose-position emission tomography and computed tomography scans from head to pelvis/prostate were performed at 8 months post-transplant (Figure 2).